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Glycomic Analysis of Life Stages of the Human
Parasite Schistosoma mansoni Reveals
Developmental Expression Profiles of
Functional and Antigenic Glycan Motifs*□S
Cornelis H. Smit‡, Angela van Diepen‡, D. Linh Nguyen‡, Manfred Wuhrer§,
Karl F. Hoffmann¶, Andre´ M. Deelder§, and Cornelis H. Hokke‡
Glycans present on glycoproteins and glycolipids of the
major human parasite Schistosoma mansoni induce in-
nate as well as adaptive immune responses in the host. To
be able to study the molecular characteristics of schisto-
some infections it is therefore required to determine the
expression profiles of glycans and antigenic glycan-mo-
tifs during a range of critical stages of the complex schis-
tosome lifecycle. We performed a longitudinal profiling
study covering schistosome glycosylation throughout
worm- and egg-development using a mass spectrometry-
based glycomics approach. Our study revealed that dur-
ing worm development N-glycans with Gal1–4(Fuc1–
3)GlcNAc (LeX) and core-xylose motifs were rapidly lost
after cercariae to schistosomula transformation, whereas
GalNAc1–4GlcNAc (LDN)-motifs gradually became
abundant and predominated in adult worms. LeX-motifs
were present on glycolipids up to 2 weeks of schistoso-
mula development, whereas glycolipids with mono- and
multifucosylated LDN-motifs remained present up to the
adult worm stage. In contrast, expression of complex
O-glycans diminished to undetectable levels within days
after transformation. During egg development, a rich di-
versity of N-glycans with fucosylated motifs was ex-
pressed, but with 3-core fucose and a high degree of
multifucosylated antennae only in mature eggs and
miracidia. N-glycan antennae were exclusively LDN-
based in miracidia. O-glycans in the mature eggs were
also diverse and contained LeX- and multifucosylated
LDN, but none of these were associated with miracidia in
which we detected only the Gal1–3(Gal1–6)GalNAc
core glycan. Immature eggs also exhibited short O-glycan
core structures only, suggesting that complex fucosy-
lated O-glycans of schistosome eggs are derived primar-
ily from glycoproteins produced by the subshell envelope
in the developed egg. Lipid glycans with multifucosylated
GlcNAc repeats were present throughout egg develop-
ment, but with the longer highly fucosylated stretches
enriched in mature eggs and miracidia. This global anal-
ysis of the developing schistosome’s glycome provides
new insights into how stage-specifically expressed gly-
cans may contribute to different aspects of schistosome-
host interactions. Molecular & Cellular Proteomics 14:
10.1074/mcp.M115.048280, 1750–1769, 2015.
Schistosoma blood flukes give rise to infections in over 200
million people in developing countries worldwide (1). With a
Disability-Adjusted Life Years (DALY) value of more than 3
million, schistosomiasis ranks as one of the neglected tropical
diseases with the highest impact on public health (2). The
schistosome has a complex and intriguing lifecycle, which
involves a definitive host (mammal) as well as an intermediate
host (snail). Infections with Schistosoma mansoni, one of the
major schistosome species infecting humans, are initiated
when snail-borne cercariae penetrate intact skin. The cercar-
iae then transform into schistosomula, which enter the vas-
culature of the host and mature while migrating to the portal
system. Here, adult male and female worms pair, with the
female worm producing hundreds of eggs each day during a
life span of several years unless the infection is treated by
chemotherapy. Miracidia develop inside the maturing eggs
while they cross the intestinal wall over a period of several
days to be excreted with the feces. Miracidia then hatch from
the eggs upon contact with fresh water and infect the snail
host where asexual replication takes place and eventually new
cercariae are shed. Notably, many eggs get trapped in organs
such as the liver, where they induce a granulomatous inflam-
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mation and organ damage, the main cause of pathology in
schistosomiasis (1).
Throughout their lifecycle, schistosomes express a multi-
tude of protein- and lipid-linked glycans that play an important
role in the parasite biology. The expression of many glycan
elements appears to be developmentally regulated by the
differential expression of glycosyltransferases during the dif-
ferent lifecycle stages (3). A series of papers has been pub-
lished indicating that schistosome glycans play essential roles
in the molecular interaction of the parasite and the host im-
mune system, enabling survival of the parasite and allowing
chronic infection to establish. For example, glycosylated sol-
uble egg antigens (SEA) interact with the C-type lectins man-
nose receptor (MR), macrophage galactose-type lectin (MGL)
and dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-
SIGN), and some of these interactions lead to immunomodu-
latory effects of specific components of SEA via dendritic
cells (DCs)1 (4, 5). Furthermore, fucosylated egg glycolipids
trigger innate immune responses of peripheral blood mono-
nuclear cells and egg glycans are required for periovular gran-
uloma formation in a mouse model. In addition, cercarial
secretions induce alternatively activated macrophages in a
carbohydrate dependent manner (6–9). Importantly, also
adaptive immune responses to schistosome glycans are
mounted by the human host. A large part of the antibody
responses to schistosomes is directed against antigenic gly-
can motifs, raising the question whether they could form a
basis for antischistosome vaccine strategies (10).
Rapid developments in mass spectrometry-based glycan-
analysis technology in the last two decades have led to sev-
eral studies focused on elucidating the glycan structures of
somatic and secretory schistosome preparations (11–22).
Among the typical glycan elements detected in S. mansoni
were unusual and antigenic Fuc1–2Fuc1–3- (DF-) motifs
attached to GalNAc1–4GlcNAc (LacDiNAc or LDN) (12, 14,
17–19, 21), Xyl1–2- and Fuc1–3-modified N-glycan core
structures (13, 15, 17, 20), and a unique O-glycan core
(Gal1–3(Gal1–6)GalNAc) (14, 17) (see supplemental Table
S5 for a definition of glycan motifs of S. mansoni glycocon-
jugates). Also more widely occurring glycan elements shared
with the mammalian or snail host were detected, e.g. Gal1–
4GlcNAc (LacNAc or LN), Gal1–4(Fuc1–3)GlcNAc (Lewis X
or LeX), LDN, and GalNAc1–4(Fuc1–3)GlcNAc (LDN-F) (23,
24). These data were generated over a long period of time,
often focusing on a single schistosome life stage and a spe-
cific class of glycans only, and using various analytical tech-
niques and strategies that make inter-study comparisons of-
ten difficult. In addition, glycosylation of the schistosomula
that develop shortly after infection and are considered to be
relatively vulnerable to immune attack, has remained largely
unexplored (20, 25, 26), although these could be interesting
therapeutic targets (27–29). Clearly, an integrated and com-
plete overview of schistosome glycosylation was so far not
available.
In this study, we therefore set out to determine the overall
schistosome protein- and lipid-linked glycome by analyzing a
total of 16 lifecycle stages ranging from cercariae to miracidia.
We analyzed the glycoprotein-derived N- and O-glycans as
well as the lipid-derived glycans of these life stages by a
MALDI-TOF MS-based approach complemented with frag-
mentation and enzyme degradation studies. Our findings give
new insights in the glycobiology of parasite development and
parasite–host interaction and contribute to the identification
of new potential immune intervention targets.
EXPERIMENTAL PROCEDURES
Glycoprotein and Glycolipid Preparations—Puerto Rican-strains of
S. mansoni maintained in the laboratories of LUMC and Aberystwyth
University were used throughout this study. For the N-glycan analysis
the protein/glycoprotein samples were obtained from the various life
stages by TRIzol (Invitrogen, Paisly, UK) extracted homogenates gen-
erated as described before (3). Parasite preparations forO-glycan and
lipid-glycan release were obtained separately as follows. Cercariae
collected from Biomphalaria glabrata snails were transferred to pre-
warmed (37 °C) medium199 (Gibco Life Technologies, Bleiswijk, The
Netherlands) containing 10 mM HEPES (Sigma-Aldrich, Zwijndrecht,
The Netherlands), 1 antibiotic antimycotic solution (Sigma-Aldrich)
and 15 M L-glutamine (Sigma-Aldrich) to induce transformation. After
20 min incubation at 37 °C and 5% CO2 schistosomula were sepa-
rated from loose tails by orbital shaking. Schistosomula were col-
lected and cultured for 3, 24, 48, and 72 h at 37 °C and 5% CO2 in the
same medium or for 9 days in this medium supplemented with eryth-
rocytes (10 l of packed erythrocytes/200 l medium, refreshed every
24 h). Adult worms and eggs were obtained from hamsters 7 weeks
after infection, as described (30). Mature and immature eggs were
isolated by Percoll gradient centrifugation (31). Miracidia were ob-
tained from eggs hatched in distilled water and collected as previ-
ously described (30). All parasite isolates were subjected to extraction
by potter homogenization in chloroform, methanol (MeOH), and water
(13:7:4). The upper phase of the extraction was removed after soni-
cation and centrifugation and replaced by the same volume of 50%
MeOH. These steps were repeated twice, however, after the last
removal of the upper phase the proteins were pelleted by adding an
1 The abbreviations used are: DC, dendritic cell; MR, mannose
receptor; MGL, macrophage galactose-type lectin; DC-SIGN, den-
dritic cell-specific ICAM-3-grabbing nonintegrin; Th2, T helper 2; F,
Fuc or fucose; DF, difucosyl or Fuc1–2Fuc1–3; TF, trifucosyl or
Fuc1–2Fuc1–2Fuc1–3; H, Hex or hexose; N, HexNAc or N-acetyl-
hexosamine; X, Xyl or xylose; Gal, Galactose; GalNAc, N-acetyl-
galactosamine; GlcNAc, N-acetylglucosamine; LDN, LacDiNAc or
GalNAc1–4GlcNAc; LN, LacNAc or Gal1–4GlcNAc; LeX, Lewis X
or Gal1–4(Fuc1–3)GlcNAc; LDN-F, GalNAc1–4(Fuc1–3)GlcNAc;
F-LDN-F, Fuc1–3GalNAc1–4(Fuc1–3)GlcNAc; F-LDN, Fuc1–
3GalNAc1–4GlcNAc; Pseudo-LeY, pseudo Lewis Y or Fuc1–
3Gal1–4(Fuc1–3)GlcNAc); CAA, circulating anodic antigen; CCA
circulating cathodic antigen; SEA, soluble egg antigens; IPSE, inter-
leukin-4-inducing principle from schistosome eggs; PNGase F, N-gly-
cosidase F; PNGase A, N-glycosidase A; rEGCase II, recombinant
endoglycoceramidase II; NAG, -N-acetylglucosaminidase from jack
bean; BKF, -L-fucosidase from bovine kidney; XMF, (1–3,4)-fuco-
sidase from Xanthomonas manihotis; JBG, (1–4,6)-galactosidase
from jack bean; 2-AA, 2-aminobenzoic acid; DHB, 2,5-dihydroxyben-
zoic acid; NMR, nuclear magnetic resonance; RP, reversed phase;
MeOH, methanol; ES, excretory secretory molecules.
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excess amount of 100% MeOH and centrifugation. Pellets were
washed three times with MeOH, dried under a flow of nitrogen, and
used for O-glycan release. For glycolipid isolation, the combined
upper phases from the chloroform-methanol extraction procedure
were applied to reversed phase (RP) C18-cartridges (500 mg; JT
Baker, Phillipsburg , NJ). Combined flow-through and wash fractions
(10 ml water) were applied to a second C18-cartridge, and glycolipids
were eluted from both cartridges with 5 ml chloroform/MeOH/water
(10:10:1) and dried combined under a flow of nitrogen.
N-glycan Release—Protein extracts were potter homogenized in
PBS with 1.3% SDS and 0.1% -mercaptoethanol. Homogenized
proteins were denatured at 60 °C for 10 min. After cooling down,
1.3% Nonidet P-40 Substitute (Sigma-Aldrich) was added. N-glycans
except those with Fuc1–3 modified core structures, were released
by adding PNGase F (17 mU, Roche Diagnostics, Almere, The Neth-
erlands) and incubation for 24 h at 37 °C. To isolate released glycans,
the incubation mixture was applied to a C18 RP-cartridge. The com-
bined flow-through and wash fraction was subsequently applied to a
carbon cartridge (150 mg Carbograph; Grace, Deerfield, IL), washed
with milliQ, and glycans were eluted with subsequent addition of 25%
acetonitrile (AcN) and 50% AcN/0.1% trifluoroacetic acid (TFA). Pro-
teins remaining on the C18-cartridge were retrieved by applying 30%
AcN containing 0.1% TFA followed by 60%AcN/0.1%TFA and dried.
The protein fraction was dissolved in PBS and incubated overnight at
37 °C while shaking in the presence of trypsin-coated Sepharose,
prepared following the manufacturers protocol (GE Healthcare, Di-
egem, Belgium), to create tryptic peptides/glycopeptides. The super-
natants were removed, dried, and taken up in 1 M sodium acetate pH
4.5, before addition of PNGase A (0.5 mU; Roche Diagnostics). Di-
gestion was continued for 48 h at 37 °C and the PNGase A released
glycans were purified as described for the PNGase F-released
glycans.
O-glycan Release—Protein pellets obtained after chloroform–
methanol extraction of parasite homogenates were subjected to re-
ductive -elimination. The dried samples were taken up in 1 M sodium
borohydride, 0.1 M sodium hydroxide, and incubated at 40 °C for
24 h. Samples were neutralized on ice by adding 4 M acetic acid.
MeOH/1% acetic acid was added repeatedly with intermediate and
final drying under a stream of nitrogen. Released glycans were taken
up in milliQ and applied to RP C18-cartridges as described before.
Combined flow-through and wash fractions were applied to a carbon
cartridge. After a wash with 6 ml water, glycans were eluted with 3 ml
25% AcN and 3 ml 25% AcN/0.05% TFA. To facilitate MALDI-
TOF-MS analyses, the purified O-glycan alditols were permethylated
according to (32). In short, glycans were lyophilized and 100 l DMSO
saturated with sodium hydroxide-powder was added. The samples
were kept for 10 min at room temperature, 100 l iodomethane was
added followed by 10 min incubation at room temperature. Dichloro-
methane (400 l) and water (500 l) were added and samples were
shaken by multiple inversions, followed by removal of the aqueous-
layer and addition of another 500 l of water. After the fifth removal of
the aqueous-layer, the remaining, washed organic layer containing
the permethylated glycans was dried under a flow of nitrogen. For
further analysis, permethylated O-glycans were dissolved in 80%
MeOH.
Lipid Glycan Release—Glycolipid extracts were dissolved in 50 mM
sodium acetate pH 5 containing 0.1% sodium taurodeoxycholate
hydrate (Sigma-Aldrich). The sample was sonicated, heated to 50 °C
for 10 min, and then incubated at 37 °C with 16 mU recombinant
endoglycoceramidase II from Rhodococcus sp. (rEGCase II) (Takara-
Bio, Otsu, Japan) for 48 h. After 24 h of incubation another 16 mU
rEGCase II was added. Released glycans were purified using RP C18-
and carbon cartridges as described above for N-glycans.
Glycan Labeling—Released reducing glycans were labeled with
2-aminobenzoic acid (2-AA), as described previously (33). Glycans
were taken up in 50 l milliQ and 50 l of labeling mix (DMSO/acetic
acid (10:3) containing 48 mg/ml 2-AA (Sigma-Aldrich) and 107 mg/ml
picoline-borane-complex (Sigma-Aldrich)) was added. Samples were
incubated at 65 °C for 2 h. Labeled glycans were taken up in 75%
AcN and were loaded on Biogel P10 (BIO-RAD, Veenendaal, The
Netherlands) conditioned with 80% AcN. The Biogel was washed with
80% AcN and glycans were eluted with milliQ.
Exoglycosidase Digestions—Selected glycan pools were treated
with specific exoglycosidases to support glycan structure assign-
ments. Each enzyme reaction mixture contained a 1 l aliquot of
labeled glycans, 6 l 100 mM sodium phosphate buffer pH 5 and 5 l
of either one of the following enzymes: -N-acetylglucosaminidase
from jack bean (NAG; 312.5 mU)(Sigma-Aldrich), -L-fucosidase from
bovine kidney (BKF; 33.3 mU)(Sigma-Aldrich), (1–3,4)-fucosidase
from Xanthomonas manihotis (XMF; 2.5 mU)(Sigma-Aldrich). For
treatment with (1–4,6)-galactosidase from jack bean (JBG) (227.3
mU) (Prozyme, Hayward, CA) 250 mM sodium citrate pH 4.0 was
used. All exoglycosidase digestions were performed at 37 °C for 24 h.
Immunofluorescence Microscopy—Cercariae and 3-day-old schis-
tosomula were washed with PBS and fixed with 2% paraformalde-
hyde. Fixed parasites were suspended in 100 l of undiluted hy-
bridoma culture supernatant containing either of the monoclonal
antibodies 291–4D10-A and 114–5B1-A, recognizing LeX- and LDN-
DF-motifs, respectively (34). After 30 min incubation at 37 °C, para-
sites were washed with PBS and suspended in 100 l of a 1:200
dilution of Alexa Fluor 488-conjugated goat-anti-mouse IgG (Life
Technologies) followed by 30 min incubation at 37 °C. Parasites
were then washed with PBS, transferred to a glass-slide and ana-
lyzed by fluorescence microscopy (Leica DM-RB (Leica, Rijswijk,
The Netherlands)).
MALDI-TOF-MS—2-AA-labeled glycans were analyzed by MALDI-
TOF-MS in the negative-ion reflectron mode with 2,5-dihydroxyben-
zoic acid (DHB, 20 mg/ml in 30% AcN, Bruker Daltonics, Bremen,
Germany) as matrix using Ultraflex II and Ultraflextreme mass spec-
trometers (Bruker Daltonics). All recorded spectra were obtained as
summed spectra of 20,000 shots. Exoglycosidase treated glycans
were purified from the digestion mixture using ZipTip C18 (Millipore,
Amsterdam, The Netherlands) following the manufacturer’s instruc-
tions and eluted directly onto the MALDI-target plate with 10 mg/ml
DHB in 50% AcN containing 0.1% TFA. Permethylated O-glycans
were analyzed in positive-ion reflectron mode using DHB as matrix.
Fragmentation ion analysis was performed using the LIFT-MS/MS
facility of the Ultraflex II and Ultraflextreme mass spectrometers.
Precursor ions were selected in a timed ion gate after 8 kV acceler-
ation, and laser-induced fragment ions were further accelerated with
16 kV in the LIFT cell and fragment masses were registered.
Interpretation of Mass Spectra, Search Parameters, and Assign-
ment Criteria—The aim of this study was to analyze and compare in
a semiquantitative manner the expression of the dominant glycans
and glycan motifs during different life stages of S. mansoni. Therefore,
we have limited spectral assignments to the relatively abundant sig-
nals only, and whenever possible we used previously published S.
mansoni glycan structural data as a basis for interpretations. Mass
spectra were smoothed and base-line subtracted using FlexAnalysis
version 3.3 (Bruker Daltonics) and peak lists were used as input for
subsequent identification of the glycan compositions in Glycopeak-
finder (http://www.glyco-peakfinder.org) (35). Peaks with a signal to
noise ratio below 3 were excluded from this analysis. For N- and
lipid-glycans, 2-AA was taken into account as a fixed reducing-end
modification and deprotonated masses were registered. O-glycans
were reduced and permethylated and masses were registered as
sodium adducts. Possible glycan compositions were allowed to have
Developmental Glycosylation of S. mansoni
1752 Molecular & Cellular Proteomics 14.7
0–20 residues of deoxyhexose, hexose and N-acetylhexosamine
each for all glycan classes and, in addition, 0–1 pentose for the
N-glycans. All compositions that matched with registered masses
with a deviation of less than 500 ppm were further evaluated manually
to assign glycan structures and consider possible isobaric and iso-
meric structures on the basis of common or previously published
specific knowledge of schistosome glycans (11–22, 36–38). In spe-
cific cases, proposed structures were confirmed by exoglycosidase
treatment (N-glycans) and fragmentation analysis (O- and lipid-gly-
cans) as described in the results section. In the MALDI-TOF-MS
spectra of N-glycans and glycolipids only the structure of the most
likely or most abundant isomer is indicated for each composition. In
case of the permethylated O-glycans, minor signals caused by under-
methylation were not annotated.
Quantification—This study was primarily designed as a qualitative
assessment of developmental glycosylation of schistosomes. For
each mass spectrum of PNGase F-sensitive glycans, the relative
quantity of a number of relevant glycan types and motifs within the
overall glycan set of that life stage was estimated from the summed
area of the two highest isotope signals for each glycan as a percent-
age of the total area of all glycan-signals in the spectrum. Absolute
quantities and the relative ratios of the N-, O-, and glycolipid-derived
glycan classes could not be determined in this study, but a low signal
to noise ratio was interpreted as an indication for general low abun-
dance of the specific glycan class in the life stage examined, or for
absence if glycan derived signals were undetectable. Qualitative re-
producibility of the data was confirmed by comparing profiles of the
different glycan classes derived from biological duplicates or tripli-
cates of cercariae, adult worms, and eggs, and in addition by com-
parison with published data as indicated in the Results section.
RESULTS
Overviews of protein- and lipid-linked glycosylation of up to
16 S. mansoni life stages were generated. Protein extracts of
all life stages studied were subjected to digestion with
PNGase F, followed by digestion with PNGase A to release
PNGase F resistant N-glycans with a Fuc1–3-modified core
(core(3)-Fuc), if present (13, 15, 17, 20). O-glycans and lipid-
glycans were obtained from additional protein and lipid ex-
tracts by reductive -elimination and by digestion with endo-
glycoceramidase, respectively. The reducing N-glycans and
glycolipid-glycans were derivatized with 2-AA, O-glycan aldi-
tols were permethylated, and all glycans were subsequently
analyzed by MALDI-TOF-MS. Resulting data for N-glycans,
O-glycans, and lipid-glycans will be presented and discussed
in relation to worm development and egg maturation.
N-glycans—N-glycans released by PNGase-F were de-
tected in all life stages studied. During the development from
cercariae to adult worms, N-glycan profiles of consecutive
stages overlap, displaying mainly changes in the relative peak
intensities, but ultimately worm maturation leads to the ap-
pearance of adult worm-specific glycans in addition to the
complete disappearance of specific larval N-glycans. Sharply
different N-glycomes are observed between the worm and
egg stages (Fig. 1A–1C, supplemental Fig. S1A–S1J, and Fig.
2A, 2B, 2D). After cleavage of the PNGase F-sensitive N-
glycans, we performed a subsequent digestion with PNGase
A for each life stage. In line with previous reports (13, 17, 20),
core(3)-Fuc modified N-glycans were not detectable in the
cercariae to adult worm range, whereas PNGase A treatment
of mature egg and miracidia glycoproteins gave rise to an
abundant set of core(3)-Fuc substituted N-glycans with
unique compositions and structures compared with the
PNGase F released N-glycans (Fig. 2C, 2E compared with Fig.
2B, 2D).
To facilitate the assignment of all N-glycan spectra re-
corded we first interpreted and validated N-glycan spectra of
cercariae, 3-day-old schistosomula, 6-week-old worms and
mature eggs to serve as a template for annotation of the
spectra obtained for the other stages. For the purpose of
relative quantification of selected N-glycan elements during
worm development (Fig. 3) we assigned the 20 most intense
glycan-derived signals in each spectrum, complemented with
the next most abundant signals to cover up to 95% of the area
of all glycan signals in the spectrum, except when the area of
the individual signals was less than 1% of the total.
N-glycans of Cercariae—The N-glycan spectrum of cercar-
iae (Fig. 1A) is highly similar to the previously published cer-
carial N-glycan spectra (15, 20). Dominant are the mono- or
di-antennary glycans with Fuc1–6- and Xyl1–2-modified
core structures (core(6)-Fuc and core-Xyl, respectively) and
the antenna motifs LN and/or LeX. Representative signals
derived from glycans with the composition X1F1–2H4N3 (X,
xylose, Xyl; F, fucose, Fuc; H, hexose, Hex; N, N-acetylhexo-
samine, HexNAc) were observed at m/z 1673.6 [M-H] and
m/z 1819.6 [M-H], whereas signals derived from X1F1–3H5N4
were found at m/z 2038.7 [M-H], 2184.7 [M-H], and m/z
2330.8 [M-H]. The presence of core-fucose within all of
these structures was confirmed by digestions with XMF. Un-
der the conditions applied, XMF cleaves of Fuc in the context
of LeX, but not core-Fuc (36, 39). After digestion, abovemen-
tioned peaks shifted because of the loss of up to two LeX-
associated Fuc-residues to m/z values corresponding to the
presence of one remaining core(6)-Fuc (i.e. X1F1H4N3 at m/z
1673.4 [M-H] and X1F1H5N4 at m/z 2038.5 [M-H]
 (Table I).
All other cercarial N-glycans observed also carry core(6)-
Fuc, except the oligomannose glycans. Complementary proof
of the localization of Fuc-residues was obtained by digestion
with JBG, which cleaves off terminal Gal-residues in the con-
text of LN, but not of LeX. Original signals shifted in the JBG
digestion-spectrum because of the loss of one or two Gal
residues to m/z-values corresponding to X1F1H3N3 at m/z
1511.4 [M-H], X1F1H3N4 at m/z 1714.5 [M-H]
, and
X1F2H4N4 at m/z 2022.6 [M-H]
, whereas X1F2H4N3 at m/z
1819.5 [M-H] and X1F3H5N4 at m/z 2330.7 [M-H]
 did not
shift because of the presence of one and two LeX antenna,
respectively (Table I). In addition, a set of similar glycans, but
lacking the core-xylose was found in the original spectrum at
m/z 1541.6 [M-H] (F1H4N3), 1687.6 [M-H]
 (F2H4N3), 1906.6
[M-H] (F1H5N4), 2052.7 [M-H]
 (F2H5N4), and m/z 2198.7
[M-H] (F3H5N4). Structures were confirmed by exo-glycosi-
dase treatment in the same way as for the xylosylated series
(Table I). Oligomannosidic glycans (H6–9N2), indicated by sig-
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nals at m/z 1516.5 [M-H], 1678.5 [M-H], 1840.6 [M-H],
and 2002.6 [M-H], and paucimannosidic glycans detected at
m/z 1308.5 [M-H]and 1176.5 [M-H] (X1F1H3N2 and F1H3N2
respectively) were observed at low levels relative to the com-
plex-type glycans. Furthermore, relatively minor signals were
observed representing glycans with one LN and one trun-
cated antenna (e.g. m/z 2022.7 [M-H] (X1F2H4N4), 1876.6
[M-H] (X1F1H4N4), and 1890.6 [M-H]
 (F2H4N4)) or with a
fucosylated LDN-antenna (e.g. 2006.6 [M-H] (X1F3H3N4)).
Glycans carrying either GlcNAc or LDN-antennae were af-
fected by NAG treatment, which cleaves off all unsubstituted
HexNAc residues (Table I). It is not possible to discriminate
between an unsubstituted LDN disaccharide unit, or two sin-
gle terminal GlcNAc residues on the basis of NAG treatment,
but HexNAc2-fragments indicative for the presence of LDN
have previously been detected as part of the N-glycans of
cercariae (15) and we therefore assume that two HexNAc
residues in the context of an N-glycan core form a single
LDN-antenna. Finally, in cercariae we did not find indications
for the presence of tri- or tetra-antennary glycans, DF-motifs,
and core(3)-Fuc. These observations are in accordance with
previous reports (15, 20).
N-glycans of 3-Day-Old Schistosomula—The N-glycan
spectrum of 3-day-old schistosomula is shown in Fig. 1B. In
line with previous findings (20), the major signals are attribut-
able to oligomannosidic structures (i.e. H5–10N2 at m/z 1354.6
[M-H], 1516.7 [M-H], 1678.8 [M-H], 1840.8 [M-H],
2002.9 [M-H], and 2165.0 [M-H]). Signals corresponding to
core(6)-fucosylated mono- and di-antennary glycans with
LN and/or LeX antennae but without core-Xyl, were also rel-
atively abundant at m/z 2199.1 [M-H] (F3H5N4), 1906.9 [M-
H] (F1H5N4), 2053.0 [M-H]
 (F2H5N4), 1687.8 [M-H]

FIG. 1.MALDI-TOF-MS of N-glycans released by PNGase F from S. mansoni cercariae A, 3 day schistosomula, B, and 6 week worms,
C. The 2-AA-labeled glycans were analyzed in negative-ion reflectron mode. All signals are labeled with monoisotopic masses and structures
were deduced from these masses on the bases of exoglycosidase digestions and published data. Red triangle, fucose; yellow circle, galactose;
blue square, N-acetylglucosamine; green circle, mannose; yellow square, N-acetylgalactosamine; white star, xylose. M5-M9 oligomannosidic
N-glycans with five to nine mannose residues. M10, oligomannosidic N-glycan with nine mannose and one glucose residue. Signals
corresponding to a hexose oligomer of unknown origin are marked with *. Nonglycan signals are marked with #.
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FIG. 2.MALDI-TOF-MS of N-glycans released by PNGase F from S. mansoni immature eggs, A, mature eggs, B, and miracidia, D, and
the PNGase A-sensitive N-glycans of mature eggs, C, and miracidia, E. The 2-AA-labeled glycans were analyzed in negative-ion reflectron
mode. All signals are labeled with monoisotopic masses and structures were deduced from these masses on the bases of exoglycosidase
digestions and published data. Red triangle, fucose; yellow circle, galactose; blue square, N-acetylglucosamine; green circle, mannose; yellow
square, N-acetylgalactosamine; white star, xylose. M5–M9 oligomannosidic N-glycans with five to nine mannose residues. Signals corre-
sponding to a hexose oligomer of unknown origin are marked with *. Nonglycan signals are marked with #.
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(F2H4N3), 2272.1 [M-H]
 (F1H6N5), 1541.7 [M-H]
 (F1H4N3),
and 2231.1 [M-H] (F1H7N4). Guided by the exoglycosidase
treatments (supplemental Table S1), this F1H7N4-species was
assigned to a hybrid glycan with a tandem repeat LN-anten-
nae. Signals derived from additional hybrid glycans (e.g. at
m/z 1719.8 [M-H] (H6N3) and 2069.0 [M-H]
 (F1H6N4)) were
observed at low abundance. The F1H6N5-species at m/z
2272.1 [M-H] represents a tri-antennary structure (supple-
mental Table S1). Structures with a core(6)-Fuc and LeX/LN-
antennae together with the core-Xyl modification (i.e.
X1F2H4N3 at m/z 1819.9 [M-H]
 and X1F1–3H5N4 at m/z
2039.0 [M-H], 2185.0 [M-H], and 2331.1 [M-H]) were
found at much lower levels than in cercariae. Similar to cer-
cariae, N-glycans expressing truncated antennae and LDN-
antennae (F1H3–4N4 atm/z 1582.8 [M-H]
 and 1744.8 [M-H])
were observed at low levels.
N-glycans of 6-Week-Old Adult Worms—The most abun-
dant glycans detected in the adult worm N-glycan spectrum
(Fig. 1C) are the oligomannosidic glycans ranging from H5N2
to H10N2, and complex glycans expressing LDN-motifs ob-
served atm/z 1582.7 [M-H] (F1H3N4) andm/z 1988.8 [M-H]

(F1H3N6) for the mono- and di-antennary species, respec-
tively. Glycans with one or two fucosylated LDN antenna were
found to be expressed in relatively high amounts as well
(F2–3H3N6 at m/z 2134.9 [M-H]
 and 2281.0 [M-H]), and
these observations are in accordance with our previous study
of separate male and female worm N-glycans (11). Aided by
the same study, the signal atm/z 2395.0 [M-H]was assigned
to a glycan with a tandem-repeat of LDN (F1H3N8). Combina-
tions of LDN-antennae and other antennae elements such as
LN (m/z 1947.8 [M-H] (F1H4N5)), and truncated antennae
(m/z 1785.7 [M-H] (F1H3N5)) were also present at consider-
able levels. Relatively low abundant signals were observed for
LeX-containing glycans (F2–3H5N4 observed at m/z 2052.8
[M-H] and 2198.9 [M-H]). The peaks at m/z 2271.9 [M-H]
(F1H6N5) and 2109.9 [M-H]
 (F1H5N5) were derived from tri-
FIG. 3. Expression levels of different
N-glycan classes A, and glycan motifs
(B–D) among the PNGase F-sensitive
N-glycans during S. mansoni worm
development. Glycan motifs shown are
core-xylose and core(6)-Fuc, B, LeX-
antennae, either one (1; dark bars) or two
(2; light bars) in a single glycan, C, and
LDN-antennae, either one (1; dark bars)
or two (2; light bars) in a single glycan, D.
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antennary glycans, as confirmed by exoglycosidase digestion
by JBG, leading to a loss of up to three Hex residues (sup-
plemental Table S2). In contrast to the early life-stages, the
complex type-glycans of adult worms differ dramatically with
respect to core-modifications (core-Xyl absent in adult
worms) and antennae-motifs (predominantly LDN in adult
worms).
Changes in the Expression of N-glycan Motifs During the
Development of Schistosome Cercariae to Adult Worms—N-
glycan spectra (Supplemental Fig. S1A–S1J) recorded of the
remaining stages of cercariae to adult worms development
were interpreted on the basis of the compositions derived
from the observed m/z values and exoglycosidase treatment
of the life stages described above. The derived relative abun-
dance of a number of characteristic structural motifs in the
N-glycans over the course of worm development is depicted
in Fig. 3A–3D (see also supplemental Table S4). Among four
different general types of N-glycans (oligomannosidic, pauci-
mannosidic, complex-type, and hybrid), pronounced shifts in
the ratio between complex-type and oligomannosidic glycans
are particularly clear (Fig. 3A). In cercariae, complex-type
glycans and oligomannosidic glycans were detected in a ratio
of 9:1 changing to a ratio of about 1:2 in 6-day-old-schisto-
somula, and then gradually to 1:1 in the adult worms. Pauci-
mannosidic and hybrid-type glycans were expressed at rela-
tively low overall levels of less than 10% throughout the whole
range.
Schistosome N-glycans are carriers of core-modifications
and terminal motifs that provoke humoral and cellular immune
responses (40–44). The antigenic core-Xyl element is ex-
pressed on 70% of all cercarial N-glycans, but its expression
rapidly decreases in the schistosomula stages, becoming un-
detectable in worms after 2 weeks of development (Fig. 3B). In
contrast, the nonantigenic common core(6)-Fuc modifica-
tion that is mainly associated with complex-type glycans, was
found to be abundant throughout schistosome development
(Fig. 3A, 3B). Changes in N-glycan motifs during development
of cercariae to adult worms are in particularly clear for LeX
and LDN antigens. LeX was abundant in cercarial N-glycans
(70% carry one or two LeX-antennae) (Fig. 3C) but levels of
N-glycans expressing LeX rapidly decline during development
to levels below 10%. In contrast, LDN-carrying structures
showed the opposite pattern (Fig. 3D) with glycans containing
one LDN-antenna increasing from around 2% in cercariae to
18% in the adult worms, and structures with two LDN-anten-
nae from less than 1% to 12% of the total N-glycome. This
means that among the complex-glycans in adult worms the
LDN-antennae are dominant. Expression of fucosylated LDN-
motifs was relatively constant within the PNGase F-released
glycans over the different lifecycle-stages, with expression
levels between 3 and 6% (supplemental Table S4). It is not
possible to discriminate between the different structural iso-
mers of these fucosylated LDN-elements on the basis of
MALDI-TOF mass spectra alone. However, from the more
detailed glycosidase treatment-assisted analysis of the cer-
carial, 3-day-old schistosomula and adult worms stages it can
be concluded that N-glycans during worm development do
not carry the Fuc3GalNAc-R (in F-LDN, F-LDN-F) or Fuc1–
2Fuc1-R (DF) elements, suggesting that 3–6% of all N-gly-
can structures in the cercariae to adult worm life stages
express LDN-F.
N-glycans of Mature Eggs—As a basis for the assignment
of N-glycans during egg development we first analyzed, the
mature egg. The spectrum of PGNase F-sensitive glycans of
the mature eggs is shown in Fig. 2B and that of the PNGase
A-sensitive glycans in Fig. 2C. Both strongly resembled pre-
viously published spectra (13, 20). Signals of oligomannosidic
glycans (H5–9N2) are abundant among the PNGase F-sensitive
glycans as is the tri-mannosyl glycan with both core(6)-Fuc
and core-Xyl (X1F1H3N2 at m/z 1308.4 [M-H]
). The species
observed atm/z 2006.7 [M-H] (X1F3H3N4) corresponded to a
glycan with core(6)-Fuc and core-Xyl, and two HexNAcs and
two Fuc-residues in the antennae. Based on the digestions
with BKF, XMF, and NAG (supplemental Table S3) and data
published by Khoo et al. (13), we concluded that this glycan
carries an LDN antenna with a Fuc1–2Fuc1–3 motif linked
to the GlcNAc residue (LDN-DF). This glycan element is com-
pletely resistant to fucosidase treatment with BKF and XMF,
but NAG treatment leads to the loss of the unsubstituted
GalNAc residue. Extensions of this glycan with additional
fucoses were observed at m/z 2152.7 [M-H] (X1F4H3N4 (F-
LDN-DF)), and m/z 2298.8 [M-H] (X1F5H3N4 (DF-LDN-DF)).
Signals atm/z 2168.7 [M-H],m/z 2314.8 [M-H], and 2460.8
[M-H] (X1F3–5H4N4) correspond to glycans with one LeX-
antenna, and one truncated antenna consisting of a GlcNAc
residue substituted with a difucosyl or trifucosyl element
(Fuc1–2Fuc1–3GlcNAc1–2R (DF-GlcNAc) or Fuc 1–
2Fuc1–3GlcNAc1–2R (TF-GlcNAc)). Other relatively
abundant glycans carrying LN and LeX motifs were found at
m/z 1906.6 [M-H], 2052.7 [M-H], 2198.7 [M-H] (F1–3H5N4),
m/z 2330.8 [M-H] (X1F3H5N4), and at m/z 1947.6 [M-H]
,
2093.7 [M-H] (F1–2H4N5 together with LDN(-F) motifs). Fi-
nally, in the PNGase F released glycan pool we observed a
characteristic signal at m/z 2526.8 (X1F1H3N8), corresponding
to a glycan with core(6)-Fuc, core Xyl and three LDN-an-
tenna. Notably, the core(3)-Fuc containing variant of the
latter glycan is the main component of the PNGase A-specific
N-glycan pool of mature eggs (Fig. 2C), giving rise to a signal
m/z 2673.0 [M-H] (X1F2H3N8). This glycan composition
matches with the major glycan present on the abundant egg
glycoprotein kappa-5 (36). Fucosylated variants, carrying one
or more LDN-F elements previously also detected on kap-
pa-5, were detected in the overall glycan pool at m/z 2965.1
[M-H] (X1F4H3N8) and 2819.0 [M-H]
 (X1F3H3N8). Interest-
ingly, in the same PNGase A glycan pool, the glycans with LeX
antenna are mostly not xylosylated (mono-antennary F3H4N3
at m/z 1833.7 [M-H], di-antennary F2–4H5N4 at m/z 2052.8
[M-H], 2198.8 [M-H], and 2344.9 [M-H], or tri-antennary
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F3H6N5 at m/z 2563.9 [M-H]
). These LeX-bearing glycans
have previously been found on the major excretory/secretory
egg glycoproteins, IPSE/alpha-1 and omega-1 (37, 38). Other
structures observed carry combinations of LDN, LDN-F, LN,
or LeX-antennae. The structural characteristics of the PNGase
A released glycans are strikingly different from the PNGase F
sensitive pool, not only with respect to the core modifications
but also in terms of antenna motifs.
N-glycans During Egg Development—It is likely that an
important source of N-glycans in mature egg extracts is the
miracidium, in contrast to immature eggs that contain the
undeveloped embryo (45, 46). Indeed, the PNGase F released
N-glycan profile of miracidia (Fig. 2D) resembles that of the
mature egg (Fig. 2B). The PNGase A-spectrum of the
miracidia (Fig. 2E); however, displays a striking difference with
that of the egg (Fig. 2C). Signals derived from glycans termi-
nating with a Gal residue (e.g. LN or LeX) visible in the m/z
1800–2700 range in the mature egg spectrum are completely
absent from the miracidial spectrum. Core(3)-Fuc modified
glycans of the miracidium carry exclusively LDN or fucosy-
lated LDN antenna, and the profile is dominated by the kap-
pa-5 associated core-(3/6)difucosylated, xylosylated tri-
antennary LDN-glycan (X1F2H3N8) at m/z 2673.4 [M-H]
. In
contrast to the abundance of the core(3)- and core(3/6)-
fucosylated glycans found in mature eggs and miracidia,
PNGase A-specifically released glycans were undetectable in
immature eggs (data not shown). The PNGase F-released
N-glycan profile of immature eggs (Fig. 2A) shows that in
comparison to the mature eggs the expression levels of fu-
cosylated antenna elements are low. Moreover, the major
kappa-5 associated tri-antennary LDN glycan detected atm/z
2526.8 in Fig. 2B and m/z 2526.9 in Fig. 2D is completely
absent in immature eggs, further indicating that this glycan
and its variants originate from miracidia. The core Xyl-motif
appears to be mainly associated with miracidia as well, be-
cause it is hardly detectable in immature eggs, and in mature
eggs it is almost exclusively associated with the LDN contain-
ing N-glycans attributed to the miracidium. Furthermore, the
observation that core(3/6)-difucosylated di-antennary gly-
cans with LeX termini (e.g. m/z 2198.8 and 2344.9 in Fig. 2B),
which have been found linked to the major egg E/S glycopro-
teins IPSE/1 and omega-1 (37, 38), are present in mature
eggs, but not in immature eggs or miracidia, indicates that
these glycans are characteristic for glycoproteins expressed
in egg compartments that develop during maturation.
O-glycans—O-glycans were obtained by reductive -elim-
ination of protein extracts from various schistosome life
stages and permethylated prior to MS analysis. Glycan struc-
tures were assigned on the basis of compositions and MALDI-
TOF-MS/MS fragmentations, taking into account previously
published data when available. O-glycan spectra of the life
stages studied are shown in Fig. 4A–4D and supplemental
Fig. S2A–S2H. Examples of structural characterizations by
MALDI-TOF-MS/MS are shown in supplemental Fig. S3.
O-glycan Expression During Development of Cercariae to
Adult Worms—Cercariae express a range of O-glycans (Fig.
4A). Smaller glycans detectable at m/z 738.4 [MNa] (H2N1)
up tom/z 1565.9 [MNa] (F1H4N2) are abundant, but signals
overm/z 2000 indicating compositions including multiple Fuc-
residues were also observed. As indicated in previous reports
(12, 14, 17) and in line with MALDI-TOF-MS/MS fragmentation
analyses (supplemental Fig. S3A–S3C), cercarial O-glycans
were primarily based on the schistosome-specific Gal1–
3(Gal1–6)GalNAc core (H2N1) (14) that was sometimes mod-
ified by one or two additional Gal residues (Fig. 4A). A minor
O-glycan subset was identified based on the conventional
type-2 core (m/z 779.4 [MNa]; H1N2). Similar to the N-
glycans, the major terminal motif of cercarial O-glycans is the
LeX-motif, which was present in glycans detected at m/z
1157.7 [MNa] (F1H2N2), 1361.8 [MNa]
 (F1H3N2), 1565.9
[MNa] (F1H4N2), and in several, less abundant, more elab-
orate glycan-structures. The presence of the LeX motif was
confirmed by the observation of a characteristic B-type frag-
ment-ion at m/z 660 [MNa] (F1H1N1) in the fragmentation
analyses (supplemental Fig. S3B–S3C). Structures with non-
fucosylated terminal elements (LN or GlcNAc) were also ob-
served, e.g. at m/z 983.6 [MNa] (H2N2), 1187.7 [MNa]

(H3N2) (fragmentation pattern shown in Supplemental Fig.
S3A), and m/z 1391.8 [MNa] (H4N2). Finally, the cercarial
O-glycan spectrum contained a signal in the high mass-range
at m/z 2589.5 [MNa] corresponding to the highly fucosy-
lated glycan with composition F5H2N5. This type of glycan,
most likely based on a conventional type-2 core and having
DF-LDN-DF, represents one of the previously described cer-
carial glycocalyx O-glycans (12). Based on MS signal intensity
these unique multifucosylated glycans make up a relatively
small fraction of the total O-glycome of cercariae. The overall
cercarial O-glycan spectrum (Fig. 4A) is strikingly similar to
that of the O-glycans derived from cercarial 0–3 h secretions
(17), suggesting that the most abundant cercarial O-glycans
are associated with glycoproteins excreted/secreted after
transformation into schistosomula.
To examine changes in O-glycan expression in the first
days after transformation we recorded mass spectra of O-
glycans obtained from 3h, 24h, 48h, and 3-day-old in vitro
cultured schistosomula (Supplemental Fig. S2B–S2E). Each of
these spectra were highly similar to that of cercariae. How-
ever, overall intensity gradually diminished in the developing
schistosomula to levels difficult to detect by MALDI-TOF MS
in 3-day-old schistosomula (supplemental Fig. S2B–S2E), and
to completely undetectable in 2 and 6-week-old worms (data
not shown). The absence of O-glycans detectable by MS in
mature schistosome stages has previously been described
(11). It should be noted that adult worms produce the excre-
tory Circulating Anodic Antigen (CAA) and Circulating Ca-
thodic Antigen (CCA), which both carry long O-glycan chains
with repeating di- or tri-saccharide motifs. These polysaccha-
rides are difficult to detect by MS methods in their intact form,
Developmental Glycosylation of S. mansoni
Molecular & Cellular Proteomics 14.7 1759
and their structures have previously been determined using
NMR approaches (47, 48).
O-glycans of Eggs and Miracidia—Whereas the spectra of
cercariae and schistosomula were dominated by signals be-
low m/z 1600 [MNa], the O-glycan mass spectrum of ma-
ture eggs in addition contains a large proportion of higher
mass glycan signals (Fig. 4C), in line with previous studies (13,
17). In contrast to cercariae and schistosomula, most egg
O-glycan structures are based on the mucin type-2 core
(Gal1–3(GlcNAc1–6)GalNAc), rather than the schistosomal
Gal1–3(Gal1–6)GalNAc core, possibly mixed with type-1
core (Gal1–3GalNAc)-based isomers for signals at m/z
1157.5 [MNa] (F1H2N2), 1198.6 [MNa]
 (F1H1N3) (frag-
mentation pattern shown in supplemental Fig. S3D), 1780.8
[MNa] (F2H3N3), 2025.9 [MNa]
 (F2H3N4), 2404.1
[MNa] (F3H4N4), and 2445.1 [MNa]
 (F3H3N5). Although
the Gal1–3(Gal1–6)GalNAc core glycan was detected in
eggs by a relatively intense signal at m/z 738.3 [MNa]
(H2N1), extensions thereof were only found at m/z 983.4
[MNa] (H2N2) and 1606.7 [MNa]
 (F1H3N3) (fragmenta-
tion pattern shown in supplemental Fig. S3E). Fragmentation-
analysis confirmed that for most ions examined more than
one possible isomer was underlying the registered m/z signal.
For example, the fragmentation spectrum of m/z 1198.6
[MNa] (F1H1N3) (supplemental Fig. S3D) showed charac-
teristic fragments for both a type-1 core based structure
(C-type fragment-ion at m/z 923.6 [MNa] (F1H1N2)) and
type-2 core based structures (Z-type fragment-ion at m/z
962.7 [MNa] (F1N3)). Like cercariae and schistosomula,
many O-glycans of eggs express LeX motifs, e.g. m/z 1157.5
[MNa] (F1H2N2), but in the eggs, tandem repeats of LeX
were uniquely observed e.g. atm/z 1780.8 [MNa] (F2H3N3).
FIG. 4.MALDI-TOF-MS of the permethylated O-glycans obtained by reductive -elimination from S. mansoni cercariae, A, immature
eggs, B, mature eggs, C, and miracidia, D. Glycans were analyzed as sodium-adducts in positive-ion reflectron mode. All signals are labeled
with monoisotopic masses and structures based on the results of MALDI-TOF MS/MS fragmentations (masses indicated in black) supple-
mented with literature data (masses indicated in red). Red triangle, fucose; yellow circle, galactose; blue square, N-acetylglucosamine; yellow
square, N-acetylgalactosamine. Signals corresponding to a hexose oligomer of unknown origin are marked with *. Nonglycan signals are
marked with #.
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Furthermore, in particular the higher mass egg O-glycans
possess LDN-motifs, often as a (multi)fucosylated form, e.g.
LDN-F at m/z 1198.6 [MNa] (F1H1N3) (supplemental Fig.
S3D), F-LDN-F or LDN-DF at m/z 2211.0 [MNa] (F4H1N5)
and DF-LDN-DF at m/z 2907.3 [MNa] (F8H1N6). Finally,
more unusual motifs were found at m/z 1647 [MNa]
(F1H2N4) and 1821.8 [MNa]
 (F2H2N4), indicative of the
presence of F-LDN with an additional hexose-residue, based
on observations in literature (17) most likely galactose, and at
m/z 1402.6 [MNa] (F1H2N3) where a LeX-element was
capped with an additional HexNAc, most likely GlcNAc (17).
Thus, the egg-stage O-glycans are characterized by a multi-
tude of different terminal motifs, of which LeX and (multi)fu-
cosylated LDN appear to be the most abundant. The predom-
inant core types were mucin type-2 and to a lesser extent
type-1.
In sharp contrast to the mature egg, the O-glycan spectrum
of miracidia contains only a single major glycan signal (Fig.
4D) at m/z 738.4 [MNa] (H2N1). MS/MS-analysis indicated
two hexose-residues attached to a reducing-end N-acetyl-
hexosamine, most likely corresponding to the Gal1–
3(Gal1–6)GalNAc O-glycan-core (supplemental Fig. S3F).
This striking finding suggests that, in contrast to the N-gly-
cans of miracidia, which are abundant and diverse, miradicia
contribute with only a single type of O-glycan to the very
complex O-glycome of eggs. Similarly contrasting, the O-gly-
can spectrum of immature eggs is dominated by the H2N2
glycan observed at m/z 983.6 [MNa], and other O-glycans
are hardly detectable (Fig. 4B). These observations suggest
that theO-glycans of schistosome eggs are mainly associated
with glycoproteins originating from egg compartments that
form after maturation, but that are not part of the miracidium.
Lipid Glycans—Glycolipid glycans were released by endo-
glycoceramidase and, after 2-AA-labeling, analyzed by
MALDI-TOF-MS. Lipid-glycan spectra of the lifecycle stages
studied are shown in Fig. 5A–5E and Supplemental Fig. S4A–
S4J. Putative annotations of the mass spectra were per-
formed in accordance with structural observations in earlier
publications when available (18, 19, 21, 22), and when re-
quired MALDI-TOF-MS/MS fragmentations were recorded to
further substantiate assignments (supplemental Fig. S5).
Lipid Glycosylation During the Development of Cercariae to
Adult Worms—According to literature (18, 19, 21, 22, 49), all
schistosome glycolipids are based on the so-called schisto-
core GalNAc1–4Glc, where the glucose is attached to the
ceramide-portion. In cercariae (Fig. 5A), one or more GlcNAc-
moieties in a linear stretch with (oligo-)fucosyl side-chains
could be found attached to this core, whereas the core itself
was never found to be fucosylated (22). In full accordance
with Wuhrer et al. (22), the most abundant lipid glycans in
cercariae terminated with Hex or Fuc-Hex, thus giving rise to
LeX- and pseudo-LeY-motifs (Fuc1–3Gal1–4(Fuc1–
3)GlcNAc). Major LeX containing glycans were found at m/z
1014.6 [M-H], 1217.7 [M-H], and 1420.8 [M-H] (F1H2N2–4).
Glycans with pseudo-LeY were found at m/z 1160.7 [M-H],
1363.8 [M-H], 1566.9 [M-H], 1770.0 [M-H] (F2H2N2–5), and
atm/z 1713.0 [M-H] (F3H2N4), 1916.1 [M-H]
, 2062.2 [M-H]
(F3–4H2N5) with (multiple) additional fucosylated GlcNAc res-
idues. Glycans terminating with two HexNAc-residues, most
likely representing LDN-termini (22), were found at lower lev-
els. Signals corresponding to glycans with F-LDN and F-
LDN-F were seen at m/z 1201.7 [M-H] (F2H1N3), 1258.8
[M-H], 1404.8 [M-H] (F1–2H1N4), and 1608.0 [M-H]

(F2H1N5). LDN epitopes presumably with (multiple) DF-motifs
were found at m/z 1347.8 [M-H], 1493.9 [M-H] (F3–4H1N3)
and 1550.9 [M-H], 1754 [M-H] (F3H1N4–5). Moreover, a
heavily fucosylated glycan with trifucosyl (TF) side-chains and
DF-motifs was found at m/z 2776.6 [M-H] (F10H1N5). Finally,
we observed glycans with tandem-repeats of LeX or a unique
Hex-Hex terminus, as confirmed by fragmentation analysis
(supplemental Fig. S5). These structures at m/z 1525.9 [M-
H], 1729.0 [M-H], 1932.1 [M-H] (F2H3N3–5), and 1541.9
[M-H] (F1H4N3) have not been described before among cer-
carial lipid glycans.
Surprisingly, the overall glycolipid glycan profile did not
significantly change after transformation of cercariae followed
by 9 days culture (supplemental Fig. S4A–S4J). Unlike the
N-glycan and O-glycan profiles, which rapidly change after
transformation, the glycolipids remain constant during the first
days of schistosomula development.
The lipid glycan spectrum of the adult worms is however
different from that of cercariae (Fig. 5A, 5B). The glycans of
the adult worms lack LeX and pseudo-LeY termini but instead
seem to exclusively terminate with fucosylated LDN. Frank et
al. (18) showed that these structures could be divided in a
group of glycans with a somewhat lower degree of fucosyla-
tion with fucoses solely present on the terminal LDN-motif,
and a group with higher fucosylated species with additional
fucosylation of the GlcNAc-backbone, and we annotated our
glycolipid glycan mass spectra accordingly. Fully in accord-
ance with Frank et al. (18) glycans expressing these fucosy-
lated LDN-motifs generally contained between three and six
HexNAc-moieties, with the species containing four HexNAcs
being the most prominent e.g. m/z 1404.5 [M-H] (F2H1N4)
and 1696.6 [M-H] (F4H1N4) carrying F-LDN-F and DF-
LDN-DF as terminal-motifs, respectively.
Surface Expression of Glycan Epitopes—In view of the dif-
ferential expression of various glycan antigens during early
worm development and the potential consequences of their
exposure to the host we were triggered to study the surface
expression of a number of terminal glycan-motifs in cercariae
and 3-day schistosomula by detection with previously de-
scribed monoclonal antibodies (34). In line with previous stud-
ies (26, 34), LeX-motifs were detected at the oral sucker of
cercariae, but 3 days after transformation we could detect
LeX over the whole surface of the parasite (Fig. 6). This
increase of surface expressed LeX-motifs in schistosomula is
in sharp contrast with the general trend that the expression of
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FIG. 5. MALDI-TOF-MS of the lipid-glycans of S. mansoni cercariae, A, adult worms, B, immature eggs, C, mature eggs, D, and
miracidia, E, released by endoglycoceramidase digestion. The 2-AA-labeled glycans were analyzed in negative-ion reflectron mode. All
signals are labeled with monoisotopic masses. Compositions were deduced based on literature and MALDI-TOF MS/MS fragmentations (for
masses indicated in red). In most cases, isomers caused by variable distribution of fucosyl residues along the backbone may occur, the most
likely and/or most abundant isomer is indicated for each mass. Red triangle, Fucose; Yellow circle, Galactose; Blue circle, Glucose; Yellow
square, N-acetylgalactosamine; Blue square, N-acetylglucosamine. Signals corresponding to hexose oligomer of unknown origin are marked
with *. Nonglycan signals are marked with #.
Developmental Glycosylation of S. mansoni
1762 Molecular & Cellular Proteomics 14.7
LeX-motifs by N- and O-glycans declines during development
(Fig. 3A, supplemental Fig. S5A–S5H). These data suggest
that, although LeX expression is high on cercarial glycopro-
teins, this motif is not exposed at the cercarial surface. Pos-
sibly, LeX surface expression after shedding of the glycocalyx
and secretion of cercarial ES is caused by exposure of the LeX
containing glycolipids that remain abundant after transforma-
tion, rather than expression on N- or O-glycan, which de-
creases instead. In contrast, for the LDN-DF-motif we ob-
served a sustained surface expression in both cercariae (34)
and 3 days schistosomula (Fig. 6). LDN-DF motifs were not
detected on N-glycans in cercariae and schistosomula, but
they are present in the O-glycan and lipid glycan pools of
these life stages.
Lipid-glycans of Eggs and Miracidia—Mature egg lipid gly-
cans were very similar to those of the adult worms with
respect to the terminal fucosylated-LDN motifs detected (Fig.
5D). Egg lipid glycans had longer HexNAc-backbones (5–7
HexNAcs) compared with the adult worm lipid glycans (4–5
HexNAcs), and showed a much higher degree of fucosylation,
in line with previously published egg lipid glycan spectra (19,
21). Strong signals of multiple glycans comprising six to eight
Fuc-moieties where observed in the mass range ofm/z 2191–
2889 [M-H]. The spectrum of the miracidia lipid glycans (Fig.
5E) was almost identical to the egg lipid glycans. No unique
signals or motifs were observed compared with mature eggs,
only slight quantitative changes. On the other hand, the spec-
trum of lipid glycans derived from immature eggs (Fig. 5C) is
shifted toward the lower mass glycans (m/z 1000–2600 [M-
H]). Therefore, miracidia appear to be a major source of the
large highly fucosylated lipid glycans in the mature eggs, but
a subset of short chain glycans with similar glycan motifs also
abundantly expressed by adult worms is present in the im-
mature eggs.
DISCUSSION
Genomic, transcriptomic, and proteomic studies of schis-
tosomes have revealed a wealth of knowledge with respect to
the developmental expression of genes and proteins during
the schistosome life cycle (3, 50–58). In the current study, we
performed a mass spectrometry-based overall glycan analy-
sis covering all developmental stages of S. mansoni that
interact with the human host, thereby filling the significant
gaps that remained in the glycomic map of the schistosome
life cycle. We identified a number of striking shifts and
switches in the expression of protein- and/or lipid-linked im-
munogenic glycan motifs.
Schistosome glycans are involved in the stimulation or
modulation of innate immune responses of the host, and they
provoke adaptive immune responses, in particular as anti-
body target (59–61). During penetration of the host’s skin and
subsequent transformation into schistosomula, schistosome
cercariae secrete a set of highly glycosylated proteins (0–3 h
ES) that facilitate entry through the skin and modulate the
immune response (62–64). We found that the overall N- and
O-glycan profiles of cercariae (Figs. 1A, 4A) are strikingly
similar to those of 0–3 h ES (17). Together with the observed
gradual decline of the total O-glycan content after transfor-
mation until O-glycans become undetectable in 3-day-old
schistosomula, this suggests that the O-glycans of the larval
schistosome stages are mainly associated with its secretions.
Similarly, the core xylosylated N-glycans with LeX antennae
that are abundant in 0–3 h ES (17) disappeared within 3 days
from the changing overall schistosomula N-glycan profile (Fig.
1A, 1B and supplemental Fig. S1A–S1D). The high-mass mul-
tifucosylated O-glycans that constitute the cercarial glycoca-
lyx (12) comprise another, however, relatively minor subset of
the total O-glycan-repertoire that disappears from the spec-
trum within days (Fig. 4A and supplemental Fig. S2A–S2E).
This subset presumably becomes undetectable in schistoso-
mula because the cercarial glycocalyx is rapidly shed upon
transformation (57, 63, 65, 66). In contrast to the N-glycans,
the lipid-derived glycan repertoire remained surprisingly sta-
ble from cercariae up to at least 9-day-old juvenile worms
(Fig. 5A and supplemental Fig. S4A–S4F). A subset of these
glycolipids carry LeX motifs, just as the cercarial N- and
FIG. 6. Surface expression of LeX- and LDN-DF-motifs in cercariae and 3 days schistosomula. Cercariae and 3 days schistosomula
were incubated with the monoclonal antibodies 291–4D10-A (antiLeX) and 114–5B1-A (antiLDN-DF) and observed by fluorescence micros-
copy. For each fluorescence image the corresponding transmitted light (Phase-Contrast) image is shown. Images for cercariae were taken with
a 10 magnification, images for 3 days schistosomula were taken at 40 magnification.
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O-glycans, but equally abundant cercariae/schistosomula
glycolipid-associated motifs are pseudo LeY and variations of
multifucosylated LDN and GlcNAc stretches. Using LeX-spe-
cific mAbs it has been shown that, in cercariae, LeX is only
present at the oral sucker, whereas in 3-day-old schistoso-
mula the whole surface displayed patches of LeX (Fig. 6) (25,
26, 34). In view of the above data, the latter observation may
be because of the surface exposure of lipid-linked rather than
protein-linked LeX in the developing schistosomulum tegu-
ment. Multifucosylated LDN elements such as the LDN-DF
motif bound by mAb 114–5B1 cover the complete surface of
cercariae (Fig. 6) (34), presumably as part of glycocalyx-as-
sociated O-glycans. Surface exposure of LDN-DF at the
schistosomula surface remains however after O-glycans have
disappeared (Fig. 6), most likely because of exposure of the
glycolipid-associated multifucosylated LDN motifs. Although
protein-associated fucosylated glycan motifs, in particular dif-
ferent structural variations of LeX, have been shown to be
directly or indirectly involved in the induction of immuno-
modulatory mechanisms by 0–3 h ES as well as by schisto-
some egg antigens (5, 64, 67), it is not known if glycolipids
from cercariae and schistosomula that carry identical glycan
motifs could also induce such effects. Innate immune re-
sponses of human PBMCs were triggered however by egg
glycolipid preparations that carry LDN-DF (6) and worm-de-
rived fucosylated glycolipids stimulate an inflammatory DC
phenotype (68), suggesting that also larval glycolipids may
trigger immunomodulatory effects if they would be appropri-
ately exposed to the host immune system.
Regardless of possible immunomodulatory properties it is
clear that many glycan motifs, either shared between lipids
and proteins (e.g. LeX, multifucosylated LDN motifs), or
unique (e.g. core-Xyl on N-glycans, O-glycan core motifs,
pseudo LeY on glycolipids) form potential targets of the anti-
body response in the schistosome-infected host (59). Using
ELISA, surface plasmon resonance, and/or glycan array ap-
proaches, antibody targets in human and animal schistosome
infection sera obtained from different endemic and experi-
mental settings and cohorts include in any case LDN, LeX,
F-LDN, LDN-F, multifucosylated variants of LDN and HexNAc,
including DF-elements, core-Xyl, and core-(3)Fuc (41–44,
69–74). It is also likely that other so far unexplored motifs
such as the additional 1–6Gal residues linked to cercarial
O-glycans (Fig. 4A) and the digalactosylated lipid glycans (Fig.
5A) are antigenic. Novel glycan array approaches using com-
plete sets of native, isolated glycans (70) will help uncover
these so far ignored glycan antigens.
Interestingly, the expression of protein-associated immuno-
genic glycan motifs appears to decrease during schistoso-
mula to worm development (Figs. 1, 3, and supplemental Figs.
S1A–S1J, S2A–S2E). It is not known to which effect, but in
particular the worm N-glycans are dominated by oligoman-
nose and LDN glycans, with relatively little fucose content.
Perhaps exposure of glycans to which no particular immuno-
genic properties have been attributed is an adaptation for
survival in the blood stream of the host, whereas the cercariae
and eggs, which have to pass the tissue to ensure develop-
ment and completion of the schistosome life cycle, favor
expression of the generally more immunogenic fucosylated
glycans. It has been shown that the LDN-motif, a disaccharide
element that occurs widely among helminths (60) can be
bound by the C-type lectin receptor MGL (75, 76), and by
galectin-3 (77) but it is unclear if these interactions lead to
functional consequences in schistosomiasis. LDN-coated
Sepharose beads as model for schistosome eggs do give rise
to the formation of hepatic granulomas in the mouse (8), but
inflammation around schistosome worms that expose LDN in
the bloodstream has not been reported. On the other hand, an
LDN-binding mAb in the presence of complement was capa-
ble of killing schistosomula in vitro (26) suggesting that LDN
may be the target of an effective immune response. Antibody
responses to LDN in schistosome-infected humans and ani-
mals have indeed been observed, but in general these seem
to be predominantly of the IgM type and rather weak, in
particular compared with antibodies against highly fucosy-
lated glycan motifs (26, 70, 71). Low antigenicity is not a
general feature of worm-associated glycan motifs however.
When schistosomula develop a gut they start to excrete a
polymeric form of LeX as part of circulating cathodic antigen
(CCA) (47), and worm glycolipids contain antigenic fucosy-
lated LDN elements similar to cercariae and eggs (18) (Fig.
5B). In developing and adult worms, F-LDN-, F-LDN-F-, and
DF-containing N- or O-glycans were not observed by MS
(Supplemental Figs. S1B–S1J and S2A–S2E). In line with this,
mAbs 114–5B1 and 114–4D12 that bind to DF-containing
motifs recognize only few worm proteins in a Western blot,
and the F-LDN-F motif has been shown to be exclusively
associated with glycolipids in parenchymal ducts of so far
unknown function in an IFA study of adult worm sections (34,
78).
The current and previous studies reveal a strong overlap
between glycan structures of schistosome cercariae and eggs
(Figs. 1A, 2, 4, 5A, 5C, 5D, 5E) (17, 20, 26, 78). Shared glycan
motifs are the cause of abundant antigen cross-reactivity
between cercariae and eggs (10, 17, 79–81). Some glycan
motifs are, however, unique to the cercariae and early schis-
tosomula, such as the pseudo LeY motif and the galactosy-
lated O-glycan core. It remains to be investigated if these
unique cercarial glycans harbor specific immunogenic prop-
erties, but they may be interesting as a target of specific
anticercarial antibodies in the development of a diagnostic
assay or for immunization against schistosome infection. Sur-
prisingly, although LeX motifs in various monomeric and mul-
timeric contexts are abundant in N- and O-glycans during
cercariae to worm development as well as egg development
(with the exception of miracidia), LeX on glycolipids only ap-
pears in cercariae and early schistosomula. The biological
relevance of the additional expression of LeX on cercarial
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glycolipids, while being absent from worm and egg glycolipids
is not known. Possibly, the absence of LeX on egg glycolipids
is the result of an overall absence of a 4-galactosyltrans-
ferase (4-GalT) activity in the egg compartments in which the
glycolipid synthesis takes place. The 4-GalT activity relative
to 4-GalNAcT seems to dramatically decrease in miracidia.
In miracidia we found exclusively LDN-based N- and O-gly-
can antennae and glycolipids, whereas nonmiracidial egg N-
and O-glycans also contain the LN-based LeX motif (Figs. 2,
4, and 5).
The immature S. mansoni egg does not yet contain a de-
veloped miracidium, nor an active subshell Von Lichtenbergs
envelope or Reynolds layer that secrete ES glycoproteins (45).
Immature eggs display an N-glycan profile dominated by non-
specific, common oligomannose glycans and LN-motifs (Fig.
2A), a lipid glycan profile that is dominated by the F-LDN-F
motif that is expressed throughout development (Fig. 5, Sup-
plemental Fig. S4A–S4J), and simple short O-glycans (Fig.
4B). The mature egg however, which does include the
miracidium as well as the subshell layers, displays highly
complex fucosylated N-glycans, including LeX, LDN substi-
tuted with F and DF, core xylose and core-(3)-Fuc (Fig. 2B,
2C). This core-(3)-Fuc modification, which occurs mainly in
combination with the core-(6)-Fuc, forming a di-fucosylated
Asn-linked GlcNAc residue, was not detectable by MS in the
other life stages studied except miracidia and mature eggs.
Also observed in mature eggs were complex and large O-
glycans with multiple LeX motifs and highly fucosylated LDN
elements (Fig. 4C), the latter group previously identified as the
target of a diagnostic mAb 114–4D12 used to detect SEA
(82). Comparison of the glycome of hatched miracidia with
that of the mature egg suggests that miracidia are the main
source of the N-glycans observed in the mature egg prepa-
ration. The PNGase F profiles of mature eggs and miracidia
are almost identical (Fig. 2B, 2D). The PNGase A profiles are
identical with respect to all core-(3)-Fuc, core-Xyl, LDN-
containing glycans, however a subset of nonxylosylated
core(3/6)-fucosylated LeX-containing glycans are unique to
the mature egg and not present in the miracidia (Fig. 2C, 2E).
The latter glycans are identical to those present on the major
ES glycoproteins IPSE/1 and omega-1 (37, 38), and they
have been identified among glycans released from ES (17).
The sites of production of IPSE/1 are the Von Lichtenbergs
envelope and Reynolds Layer (83), and for omega-1 the Von
Lichtenbergs envelope (84). We hypothesize that this subset
of LeX-containing glycans is uniquely associated with the egg
ES glycoproteins that are produced in these envelope cells
associated with the mature egg, whereas all other N-glycans,
including the dominant core-xylosylated, core-(3/6) difuco-
sylated tri-antennary LDN glycan (Fig. 2E) that was found on
kappa-5 (36) represent miracidum-derived glycoproteins.
Kappa-5 appears to be produced and secreted by the
miracidium inside the egg as it has been found in the subshell
area, however, not in the cellular layers (85). Surprisingly, in
the hatched miracidium we observed only a single short O-
glycan (Fig. 4D), and all complex and fucosylated O-glycans
observed in the mature egg (Fig. 4C) seem also to be pro-
duced by the mature egg associated subshell layers. Similar
O-glycans were indeed detected in egg ES (17), and DF-LDN-
DF-containing O-glycans were detected by IFA surrounding
the egg in frozen liver sections (82), indicating these fucosy-
lated O-glycans are associated with one or more abundant
components from egg ES. In previous studies, O-glycans
were not found on the most abundant ES glycoproteins IP-
SE/1 and omega-1 (37, 38), and it remains to be determined
which ES glycoproteins do carry these O-glycans. Like in
cercariae and adult worms (see above), O-glycosylation and
LeX-expression in eggs seem mainly associated with secre-
tions. Miracidia glycans are almost completely devoid of LeX-
or LN-motifs (Fig. 2D, 2E). In particular, the core (3/6)
di-fucosylated N-glycan pool characteristic for miracidia (Fig.
2E) is exclusively based on LDN antennae. It has previously
been shown that LeX apparently does not play a role in snail
infection as this motif is not expressed in the intra-molluscan
stages of S. mansoni. In contrast, in these stages LDN-based
motifs are abundant, both in the parasite and the intermediate
host (86–90). This cross-reactivity might indicate that the
developing miracidium already adapts a snail-compatible gly-
cosylation pattern, similar to cercariae that express high levels
of LeX motifs that may be important for successful invasion of
the human host.
An important question open for further research is how the
molecular context of a glycan motif plays a role in its immu-
nogenic properties. These properties may be dependent on
the presence on either a protein or a lipid carrier, on the
structure of the underlying glycan (combination with other
motifs, number of antennae, chain length) and on its specific
exposure on secretions or on the parasite surface during
different stages of the infection. In particular, the LeX motif
has been extensively studied in different immunological and
structural contexts. LeX as part of multivalent synthetic gly-
coconjugates has been shown to be capable of inducing and
modulating DC-SIGN and TLR4-mediated Th2 responses (91,
92) but in the context of IPSE/1 and omega-1, only LeX in
omega-1 was involved in the induction of Th2 responses, in
this case by mediating uptake of omega-1 by DC via MR (5).
SEA does however induce Th2-associated effects similar to
polyvalent LeX conjugates in certain biological systems (67,
93) and the LeX-containing O-glycans that are abundantly
expressed in ES products may play a role in this. Both cer-
carial and egg ES are rich in complex multifucosylated LDN-
containing glycans as well, but this specific group of glycans
has not been explored so far in biological/immunological
studies. Although lectin receptors for LeX, LDN and LDN-F
have been identified (75, 77, 94), no specific receptors for
other abundant motifs such as F-LDN-F and the DF-contain-
ing glycans have been described. It will be interesting to test
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if the latter group of fucosylated glycan motifs harbors similar
or perhaps contrasting immunomodulatory properties to LeX.
Regardless of their potential immunomodulatory properties,
most glycan motifs expressed on schistosome glycoconju-
gates give rise to antibodies in the infected human or animal
host. Generally higher antibody titers are observed against
schistosome/pathogen specific glycans motifs such as DF,
compared with motifs that are shared with the host such as
LeX and LDN-F (26, 70, 71), but in addition the antiglycan
responses are highly related to infection parameters (59, 70).
Although it would be out of the scope of this paper to address
the relevance of antiglycan antibodies in schistosomiasis im-
munity in detail, our data supports further research into the
question if antiglycan antibodies might serve as a decoy for
the immune system, directing antibodies away from the vul-
nerable invading schistosomulum (17), or that antiglycan an-
tibodies may be involved in protective immune mechanisms.
We believe it is relevant that some antibody targets are shared
between different life stages, in particular cercariae and eggs,
whereas others appear to be characteristic or unique for a
specific developmental stage. More research into antibody
responses in defined human and animal cohorts toward a
large number of glycan motifs and glycans described in this
study will be needed to uncover the relation of each of the
antiglycan antibodies to schistosome infection and immunity.
In conclusion, we presented the first comprehensive com-
parative analysis of schistosome glycans expressed during
interaction of the parasite with the definitive host, and gener-
ated new insights into the biology and immunology associ-
ated with antigenic schistosome glycan motifs.
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